TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Chou WC, Chou SC, Liu CY, Chen CY, Hou HA, Kuo YY, Lee MC, Ko BS, Tang JL, Yao M, Tsay W, Wu SJ, Huang SY, Hsu SC, Chen YC, Chang YC, Kuo YY, Kuo KT, Lee FY, Liu MC, Liu CW, Tseng MH, Huang CF, Tien HF.
Chou WC, et al. Among authors: huang cf, huang sy.
Blood. 2011 Oct 6;118(14):3803-10. doi: 10.1182/blood-2011-02-339747. Epub 2011 Aug 9.
Blood. 2011.
PMID: 21828143
Free article.